These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12902992)

  • 41. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.
    Comer SD; Sullivan MA; Whittington RA; Vosburg SK; Kowalczyk WJ
    Neuropsychopharmacology; 2008 Apr; 33(5):1179-91. PubMed ID: 17581533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A protocol to switch high-dose, methadone-maintained subjects to buprenorphine.
    Levin FR; Fischman MW; Connerney I; Foltin RW
    Am J Addict; 1997; 6(2):105-16. PubMed ID: 9134072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
    Correia CJ; Walsh SL; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2006 Dec; 189(3):297-306. PubMed ID: 17013637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study.
    Gerra G; Leonardi C; D'Amore A; Strepparola G; Fagetti R; Assi C; Zaimovic A; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):265-72. PubMed ID: 16309810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
    Bramness JG; Bachs LC; Waal H
    Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2452-4. PubMed ID: 12448114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia.
    Vicknasingam B; Mazlan M; Schottenfeld RS; Chawarski MC
    Drug Alcohol Depend; 2010 Sep; 111(1-2):44-9. PubMed ID: 20478668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.
    Langleben DD; Ruparel K; Elman I; Loughead JW; Busch EL; Cornish J; Lynch KG; Nuwayser ES; Childress AR; O'Brien CP
    Addict Biol; 2014 Mar; 19(2):262-71. PubMed ID: 22747521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects.
    De S; Jain R; Ray R; Dhawan A; Varghese ST
    Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An injection depot formulation of buprenorphine: extended bio-delivery and effects.
    Sigmon SC; Moody DE; Nuwayser ES; Bigelow GE
    Addiction; 2006 Mar; 101(3):420-32. PubMed ID: 16499515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependence.
    Nasser AF; Heidbreder C; Gomeni R; Fudala PJ; Zheng B; Greenwald MK
    Clin Pharmacokinet; 2014 Sep; 53(9):813-24. PubMed ID: 25015174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.
    Concheiro M; Jones H; Johnson RE; Shakleya DM; Huestis MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):13-20. PubMed ID: 19945361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid heroin detoxification using a single high dose of buprenorphine.
    Kutz I; Reznik V
    J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
    Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
    Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification.
    Sobel BF; Sigmon SC; Walsh SL; Johnson RE; Liebson IA; Nuwayser ES; Kerrigan JH; Bigelow GE
    Drug Alcohol Depend; 2004 Jan; 73(1):11-22. PubMed ID: 14687955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of high-dose intravenous buprenorphine in experienced opioid abusers.
    Umbricht A; Huestis MA; Cone EJ; Preston KL
    J Clin Psychopharmacol; 2004 Oct; 24(5):479-87. PubMed ID: 15349002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-vitro and in-vivo characterization of a buprenorphine delivery system.
    Kleppner SR; Patel R; McDonough J; Costantini LC
    J Pharm Pharmacol; 2006 Mar; 58(3):295-302. PubMed ID: 16536895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
    Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
    J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder.
    Becker WC; Ganoczy D; Fiellin DA; Bohnert AS
    J Subst Abuse Treat; 2015 Jan; 48(1):128-31. PubMed ID: 25312475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.